These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38197553)

  • 21. Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study.
    Ozdemir SP; Kurtiş B; Tüter G; Bozkurt Ş; Gültekin SE; Sengüven B; Watanabe K; Aydın S
    J Periodontol; 2012 Sep; 83(9):1172-82. PubMed ID: 22220769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect osteoblast differentiation by liposomal clodronate.
    Okada E; Nakata H; Yamamoto M; Kasugai S; Kuroda S
    J Cell Mol Med; 2018 Feb; 22(2):1127-1137. PubMed ID: 29063674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways.
    Shima K; Nemoto W; Tsuchiya M; Tan-No K; Takano-Yamamoto T; Sugawara S; Endo Y
    Biol Pharm Bull; 2016; 39(5):770-7. PubMed ID: 27150146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and tolerability of i.m. disodium clodronate 200 mg/lidocaine 1%, given twice monthly, in comparison with i.m. disodium clodronate 100 mg/lidocaine 1%, given weekly, in healthy postmenopausal female patients.
    Radicioni M; Cremonesi G; Baraldi E; Leuratti C; Mariotti F
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):313-22. PubMed ID: 23357844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.
    Reusser NM; Dalton HJ; Pradeep S; Gonzalez-Villasana V; Jennings NB; Vasquez HG; Wen Y; Rupaimoole R; Nagaraja AS; Gharpure K; Miyake T; Huang J; Hu W; Lopez-Berestein G; Sood AK
    Cancer Biol Ther; 2014 Aug; 15(8):1061-7. PubMed ID: 24841852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.
    Frediani B; Bertoldi I; Pierguidi S; Nicosia A; Picerno V; Filippou G; Cantarini L; Galeazzi M
    Clin Drug Investig; 2013 Mar; 33(3):193-8. PubMed ID: 23456672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LC-MS/MS method for the determination of clodronate in human plasma.
    Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V; Briot K; Roux C; Roy C; Seksik P; Charachon A; Bouhnik Y; Coffin B; Allez M; Lamarque D; Chaussade S
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis.
    Gomez-Barrena E; Lindroos L; Ceponis A; López-Franco M; Sanchez-Pernaute O; Mönkkönen J; Salo J; Herrero-Beaumont G; Konttinen Y
    Clin Exp Rheumatol; 2006; 24(6):622-8. PubMed ID: 17207376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clodronate in the management of different musculoskeletal conditions.
    Frediani B; Giusti A; Bianchi G; Dalle Carbonare L; Malavolta N; Cantarini L; Saviola G; Molfetta L
    Minerva Med; 2018 Aug; 109(4):300-325. PubMed ID: 29947493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of bisphosphonates in rabbits.
    Luurila S; Kautiainen S; Ylitalo P; Ylitalo R
    Pharmacol Toxicol; 1999 Jan; 84(1):24-8. PubMed ID: 9974186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).
    Mason MD; Sydes MR; Glaholm J; Langley RE; Huddart RA; Sokal M; Stott M; Robinson AC; James ND; Parmar MK; Dearnaley DP;
    J Natl Cancer Inst; 2007 May; 99(10):765-76. PubMed ID: 17505072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy.
    Kitamoto K; Machida Y; Uchida J; Izumi Y; Shiota M; Nakao T; Iwao H; Yukimura T; Nakatani T; Miura K
    J Pharmacol Sci; 2009 Nov; 111(3):285-92. PubMed ID: 19893275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.
    Jacobs C; Walter C; Ziebart T; Dirks I; Schramm S; Grimm S; Krieger E; Wehrbein H
    Clin Oral Investig; 2015 Apr; 19(3):699-708. PubMed ID: 25055746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clodronate stimulates bone formation as well as inhibits bone resorption and increases bone mineral density in rats fed a low-calcium diet.
    Horie D; Takahashi M; Aoki K; Ohya K
    J Med Dent Sci; 2003 Mar; 50(1):121-32. PubMed ID: 12715928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
    Mönkkönen H; Kuokkanen J; Holen I; Evans A; Lefley DV; Jauhiainen M; Auriola S; Mönkkönen J
    Anticancer Drugs; 2008 Apr; 19(4):391-9. PubMed ID: 18454049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clodronate in the prevention and treatment of skeletal metastasis.
    Gulley J; Dahut WL
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute renal effects of intravenous bisphosphonates in the rat.
    Pfister T; Atzpodien E; Bohrmann B; Bauss F
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):374-81. PubMed ID: 16364053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clodronate-induced cell apoptosis in human thyroid carcinoma is mediated via the P2 receptor signaling pathway.
    Yang DM; Teng HC; Chen KH; Tsai ML; Lee TK; Chou YC; Chi CW; Chiou SH; Lee CH
    J Pharmacol Exp Ther; 2009 Aug; 330(2):613-23. PubMed ID: 19448140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of tiludronate in horses: A field population study.
    Popot MA; Jacobs M; Garcia P; Loup B; Guyonnet J; Toutain PL; Bailly-Chouriberry L; Bonnaire Y
    Equine Vet J; 2018 Jul; 50(4):488-492. PubMed ID: 29194746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.